
-
Sana Biotechnology NASDAQ:SANA Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and making its therapies broadly available to patients. Sana is more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Location: | Website: sana.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
320.7M
Cash
152.5M
Avg Qtr Burn
-55.79M
Short % of Float
30.01%
Insider Ownership
8.59%
Institutional Own.
93.78%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SC262 Details B-cell malignancies | Phase 1 Data readout | |
SC291 (CD19) Details Lupus nephritis, ANCA-Associated Vasculitis | Phase 1 Data readout | |
UP421 Details Type 1 diabetes | Phase 1 Data readout | |
SC291 (CD19) Details B-cell malignancies | Phase 1 Update |